BEIZRAY J Code: J9174

Drug & Product Overview

HCPCS Descriptor Injection, docetaxel (beizray), 1 mg

HCPCS Added Date July 1, 2025

Manufacturer Zydus Pharmaceuticals

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution | Kit

About BEIZRAY

Beizray is a medication aligned to the HCPCS J Code: J9174 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by Zydus Pharmaceuticals.

According to CMS Drug Use Information: This medication is used to treat cancer (such as breast, lung, prostate, stomach, and head/neck cancer). Docetaxel is a member of a family of drugs called taxanes. This drug works by slowing cell growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 3 of 4 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
70710-2091-03	Beizray	Zydus Pharmaceuticals USA Inc.	80	Kit
70710-2092-08	Beizray	Zydus Pharmaceuticals USA Inc.	20	20 MG / 1 ML
70710-2093-04	Beizray	Zydus Pharmaceuticals USA Inc.	160	Kit
•••••-••••-•• Log in to view	BEIZRAY

Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BEIZRAY Pricing & Reimbursement

J9174 Private Payer Reimbursement

$46.06 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Docetaxel 505(b)(2) Information:

HCPCS Code	Manufacturer	Active Ingredient	HCPCS Description
J9171	Generic Code (Multiple Manufacturers)	Docetaxel	Injection, docetaxel, 1 mg
J9172	Avyxa Pharma	Docetaxel	Injection, docetaxel (docivyx), 1 mg
J9174	Zydus Pharmaceuticals	Docetaxel	Injection, docetaxel (beizray), 1 mg

BEIZRAY CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

BEIZRAY Medically Unlikely Edits (MUE)

The most billing units of J9174 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

320 units / day

= 320 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

BEIZRAY Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Breast Cancer Gastric Adenocarcinoma Head and Neck Cancer Non-small Cell Lung Cancer Prostate Cancer

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Frequently Asked Questions

Is there an available BEIZRAY billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for BEIZRAY.

Are there any available BEIZRAY patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for BEIZRAY.

Where can I find BEIZRAY prescribing information?

BEIZRAY prescribing information can be found at the link below. Visit Here →

Where can I find BEIZRAY side effect information?

We have not identified a source of side effect information for BEIZRAY.

Does billing BEIZRAY require JZ/JW wastage modifiers?

CMS does not include BEIZRAY (J9174) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9174. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.